Thrive Capital Management, LLC

Institutional investor · Portfolio as of Q3 2025

Top Holdings6 positions

Checking export access…
Activity:
FIG

Figma, Inc.

4.4M$228M47.5%$51.870.00%
1 qtr
New
Unranked
OSCR

Oscar Health, Inc.

6.3M$120.1M25.0%$16.40+15.42%
17 qtrssince 2021-Q3
Unchanged
0
CVNA

Carvana Co.

226,761$85.5M17.8%$8.10+832.02%
15 qtrssince 2022-Q1
Unchanged
0
VMEO
VMEODelisted

VIMEO INC

5.9M$45.4M9.4%——
18 qtrssince 2021-Q2
Unchanged
0
STUB

StubHub Holdings, Inc.

68,745$1.2M0.2%$16.840.00%
1 qtr
New
45
NU

Nu Holdings Ltd.

264$4,2270.0%$16.01+4.56%
1 qtr
New
23
$480.2M
AUM
6
Positions
Q3 2025
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2022-Q1$740,576,000-8.07743293631%
2022-Q2$342,270,000-53.7832713996%
2022-Q3$293,647,000-14.2060361703%
2022-Q4$220,535,810-24.8976458128%
2023-Q3$390,494,67477.0663340344%
2025-Q3$480,183,29322.9679493657%
Activity profile
$ moved · Q3'25
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q33%1-4Q0%1-2Y0%2Y+67%

Thrive Capital Management, LLC manages $480.2M across 6 positions as of Q3 2025. Top holdings: FIG (47.5%), OSCR (25.0%), CVNA (17.8%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2/5.0.

Q3 2025 Summary

Added FIG, STUB and NU. Top move: STUB (NEW, conviction 45). Portfolio: $480M across 6 positions.

Top holdings by portfolio weight

Total AUM$480M
FIG47.49%
OSCR25.01%
CVNA17.81%
VMEO9.45%
STUB0.24%
NU0.00%

Portfolio allocation by GICS sector

Sectors6
Technology47.49%
Healthcare25.01%
Consumer Cyclical17.81%
Unknown9.45%
Communication Services0.24%
Financial Services0.00%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L53
Conviction67
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used